Synthesis 2012; 44(23): 3609-3612
DOI: 10.1055/s-0032-1317506
paper
© Georg Thieme Verlag Stuttgart · New York

Stereochemically Reliable Syntheses of Pachastrissamine and Its 2-epi-Congener via Oxazolidinone Precursors from an Established Starting Material N-tert-Butoxycarbonyl-Protected Phytosphingosine

Hoon Bae
a   College of Pharmacy, Seoul National University, San 56-1, Shilim, Kwanak, Seoul 151-742, Republic of Korea   Fax: +82(2)8880649   Email: pennkim@snu.ac.kr
,
Hongjun Jeon
a   College of Pharmacy, Seoul National University, San 56-1, Shilim, Kwanak, Seoul 151-742, Republic of Korea   Fax: +82(2)8880649   Email: pennkim@snu.ac.kr
,
Dong Jae Baek
a   College of Pharmacy, Seoul National University, San 56-1, Shilim, Kwanak, Seoul 151-742, Republic of Korea   Fax: +82(2)8880649   Email: pennkim@snu.ac.kr
,
Dongjoo Lee*
b   Department of Pharmacology, College of Medicine, Dankook University, San 29, Anseo-dong, Dongnam-gu, Cheonan-si, Chungnam 330-714, Republic of Korea   Fax: +82(41)5597899   Email: drlee21@dankook.ac.kr
,
Sanghee Kim*
a   College of Pharmacy, Seoul National University, San 56-1, Shilim, Kwanak, Seoul 151-742, Republic of Korea   Fax: +82(2)8880649   Email: pennkim@snu.ac.kr
› Author Affiliations
Further Information

Publication History

Received: 04 August 2012

Accepted after revision: 06 October 2012

Publication Date:
05 November 2012 (online)


Abstract

Efficient, stereochemically unambiguous, total syntheses of pachastrissamine and its 2-epi-congener from the readily available common precursor (1R)-1-{(4S,5S)-2-oxo-4-[(trityl­oxy)methyl]-1,3-oxazolidin-5-yl}pentadecyl methanesulfonate are reported. Syntheses of (3aS,6R,6aR)- and (3aS,6S,6aR)-6-tetradecylhexahydro-2H-cyclopenta[d][1,3]oxazol-2-one by this route have unambiguously resolved a dispute over the structures of these products.

Supporting Information

 
  • References

  • 1 Bhaket P, Morris K, Stauffer CS, Datta A. Org. Lett. 2005; 7: 875
  • 2 Abraham E, Davies SG, Roberts PM, Russell AJ, Thomson JE. Tetrahedron: Asymmetry 2008; 19: 1027
    • 3a Sudhakar N, Kumar AR, Prabhakar A, Jagadeesh B, Rao BV. Tetrahedron Lett. 2005; 46: 325
    • 3b van den Berg R, Boltje T, Verhagen C, Litjens R, van der Marel G, Overkleeft H. J. Org. Chem. 2006; 71: 836
    • 3c Du Y, Liu J, Linhardt RJ. J. Org. Chem. 2006; 71: 1251
    • 3d Liu J, Du Y, Dong X, Meng S, Xiao J, Cheng L. Carbohydr. Res. 2006; 341: 2653
    • 3e Ribes C, Falomir E, Carda M, Marco JA. Tetrahedron 2006; 62: 5421
    • 3f Lee T, Lee S, Kwak YS, Kim D, Kim S. Org. Lett. 2007; 9: 429
    • 3g Reddy LV. R, Reddy PV, Shaw AK. Tetrahedron: Asymmetry 2007; 18: 542
    • 3h Ramana CV, Giri AG, Suryawanshi SB, Gonnade RG. Tetrahedron Lett. 2007; 48: 265
    • 3i Prasad KR, Chandrakumar A. J. Org. Chem. 2007; 72: 6312
    • 3j Abraham E, Candela-Lena JI, Davies SG, Georgiou M, Nicholson RL, Roberts PM, Russell AJ, Sánchez-Fernández EM, Smith AD, Thomson JE. Tetrahedron: Asymmetry 2007; 18: 2510
    • 3k Yakura T, Sato S, Yoshimoto Y. Chem. Pharm. Bull. 2007; 55: 1284
    • 3l Abraham E, Brock EA, Candela-Lena JI, Davies SG, Georgiou M, Nicholson RL, Perkins JH, Roberts PM, Russell AJ, Sánchez-Fernández EM, Scott PM, Smith AD, Thomson JE. Org. Biomol. Chem. 2008; 6: 1665
    • 3m Passiniemi M, Koskinen AM. P. Tetrahedron Lett. 2008; 49: 980
    • 3n Venkatesan K, Srinivasan KV. Tetrahedron: Asymmetry 2008; 19: 209
    • 3o Enders D, Terteryan V, Paleček J. Synthesis 2008; 2278
    • 3p Ichikawa Y, Matsunaga K, Masuda T, Kotsuki H, Nakano K. Tetrahedron 2008; 64: 11313
    • 3q Canals D, Mormeneo D, Fabriàs G, Llebaria A, Casas J, Delgado A. Bioorg. Med. Chem. 2009; 17: 235
    • 3r Reddipalli GS, Venkataiah M, Mishra MK, Fadnavis NW. Tetrahedron: Asymmetry 2009; 20: 1802
    • 3s Inuki S, Yoshimitsu Y, Oishi S, Fujii N, Ohno H. Org. Lett. 2009; 11: 4478
    • 3t Jayachitra G, Sudhakar N, Anchoori RK, Rao BV, Roy S, Banerjee R. Synthesis 2010; 115
    • 3u Vichare P, Chattopadhyay A. Tetrahedron: Asymmetry 2010; 21: 1983
    • 3v Inuki S, Yoshimitsu Y, Oishi S, Fujii N, Ohno H. J. Org. Chem. 2010; 75: 3831
    • 3w Yoshimitsu Y, Inuki S, Oishi S, Fujii N, Ohno H. J. Org. Chem. 2010; 75: 3843
    • 3x Urano H, Enomoto M, Kuwahara S. Biosci., Biotechnol., Biochem. 2010; 74: 152
    • 3y Salma Y, Ballereau S, Maaliki C, Ladeira S, Andrieu-Abadie N, Génnison Y. Org. Biomol. Chem. 2010; 8: 3227
    • 3z Passiniemi M, Koskinen AM. P. Org. Biomol. Chem. 2011; 9: 1774
    • 3aa Llaveria J, Díaz Y, Matheu MI, Castillón S. Eur. J. Org. Chem. 2011; 1514
    • 3ab Sriniavas Rao G, Venkateswara Rao B. Tetrahedron Lett. 2011; 52: 6076
    • 3ac Prasad KR, Penchalaiah K. Tetrahedron: Asymmetry 2011; 22: 1400
    • 3ad Lee H.-J, Lim C.-M, Hwang S.-H, Jeong B.-S, Kim S. Chem.–Asian J. 2011; 6: 1943
    • 3ae Cruz-Gregorio S, Espinoza-Rojas C, Quintero L, Sartillo-Piscil F. Tetrahedron Lett. 2011; 52: 6370
    • 3af Zhao M.-L, Zhang E, Gao J, Zhang Z, Zhao Y.-T, Qu W, Liu H.-M. Carbohydr. Res. 2012; 351: 126
  • 4 Sánchez-Eleuterio A, Quintero L, Sartillo-Piscil F. J. Org. Chem. 2011; 76: 5466
  • 5 Because syntheses of oxazolidinone 3 were reported independently by Yakura (2007), Ichikawa (2008), and our group (2011), spectroscopic data for the oxazolidinone structure 3 of pachastrissamine were not available until 2007; see references 3k, 3p, and 3ad.
  • 6 The first synthesis of oxazolidinone 4 was reported by our group in 2011. See ref. 7.
  • 7 Jeon H, Bae H, Baek DJ, Kwak YS, Kim D, Kim S. Org. Biomol. Chem. 2011; 9: 7234